Hart A, Gustafson S K, Skeans M A, Stock P, Stewart D, Kasiske B L, Israni A K
Department of Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis, MN.
Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN.
Am J Transplant. 2017 Jan;17 Suppl 1(Suppl 1):543-564. doi: 10.1111/ajt.14132.
In December 2014, a new kidney allocation system (KAS) was implemented in the United States in an attempt to improve access to transplant for historically underrepresented groups, and to incorporate longevity matching such that donor kidneys with the longest projected graft survival are given to recipients with the longest projected patient survival. The development of organ allocation policies is often guided by simulated allocation models, computer programs that simulate the arrival of donated organs and new candidates on the waiting list over a 1-year period to project outcomes under a new allocation method. We examined the early outcomes under the new KAS using quarterly data beginning in 2013, revealing whether trends were already underway before implementation. Quarterly data also serve to reveal any bolus effect, or a rapid rise or fall in the proportion of transplants in a given group due to reordering of the list, followed by tapering toward a new steady state. Post-KAS changes were notable for an increase in the proportion of transplants among younger candidates, black and Hispanic candidates, highly sensitized candidates, and those on dialysis for at least 5 years. Transplants among blood type B candidates increased slightly but these candidates remain underrepresented relative to their prevalence on the waiting list. Regional and national sharing increased under the new KAS, but transplants of kidneys with a kidney donor profile index above 85% decreased. Early graft survival appears unchanged, but given the increases in regional sharing, cold ischemia time, and transplants among highly sensitized candidates and candidates with long pretransplant dialysis time, long-term graft survival will need to monitored.
2014年12月,美国实施了一项新的肾脏分配系统(KAS),旨在改善历史上代表性不足群体获得移植的机会,并纳入寿命匹配机制,即将预计移植肾存活时间最长的供体肾脏分配给预计患者存活时间最长的受者。器官分配政策的制定通常由模拟分配模型指导,这些计算机程序模拟捐赠器官的到来以及候补名单上新候选者在1年时间内的情况,以预测新分配方法下的结果。我们使用始于2013年的季度数据研究了新KAS下的早期结果,以揭示在实施之前趋势是否已经显现。季度数据还用于揭示任何推注效应,即由于名单重新排序,给定群体中移植比例的快速上升或下降,随后逐渐趋向于新的稳定状态。KAS实施后的变化显著表现为年轻候选者、黑人和西班牙裔候选者、高敏候选者以及透析至少5年的患者中移植比例增加。B型血候选者中的移植略有增加,但相对于他们在候补名单上的比例,这些候选者的代表性仍然不足。新KAS下区域和全国范围内的共享增加,但肾脏捐赠者特征指数高于85%的肾脏移植减少。早期移植肾存活似乎没有变化,但鉴于区域共享、冷缺血时间的增加,以及高敏候选者和移植前透析时间长的候选者中的移植增加,需要监测长期移植肾存活情况。